CENPL expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 9.447400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
9.603600E-01
Normal-vs-Stage2
8.516800E-01
Normal-vs-Stage3
2.357200E-01
Normal-vs-Stage4
6.853600E-01
Stage1-vs-Stage2
7.409800E-01
Stage1-vs-Stage3
2.364600E-01
Stage1-vs-Stage4
5.803000E-01
Stage2-vs-Stage3
1.223810E-01
Stage2-vs-Stage4
6.195000E-01
Stage3-vs-Stage4
2.152600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
9.595000E-01
Normal-vs-AfricanAmerican
7.304800E-01
Normal-vs-Asian
8.726600E-01
Caucasian-vs-AfricanAmerican
7.516800E-01
Caucasian-vs-Asian
8.624600E-01
AfricanAmerican-vs-Asian
8.437800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
9.915000E-01
Normal-vs-Female
8.923000E-01
Male-vs-Female
6.071000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
3.656400E-01
Normal-vs-Age(41-60Yrs)
7.813000E-01
Normal-vs-Age(61-80Yrs)
9.890000E-01
Normal-vs-Age(81-100Yrs)
9.318600E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
2.100200E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
3.151000E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
1.975410E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
2.938000E-01
Age(41-60Yrs)-vs-Age(81-100Yrs)
6.818600E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
8.740400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
8.237400E-01
Normal-vs-Daily Drinker
4.036000E-01
Normal-vs-Weekly Drinker
5.648800E-01
Normal-vs-Occasional Drinker
8.981200E-01
Normal-vs-Social Drinker
7.838800E-01
Non Drinker-vs-Daily Drinker
2.541000E-01
Non Drinker-vs-Weekly Drinker
1.523420E-01
Non Drinker-vs-Occasional Drinker
4.849800E-01
Non Drinker-vs-Social Drinker
3.338400E-01
Daily Drinker-vs-Weekly Drinker
4.574200E-02
Daily Drinker-vs-Occasional Drinker
1.000960E-01
Daily Drinker-vs-Social Drinker
6.108200E-02
Weekly Drinker-vs-Occasional Drinker
3.270400E-01
Weekly Drinker-vs-Social Drinker
4.665400E-01
Occasional Drinker-vs-Social Drinker
7.957400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
7.175200E-01
Normal-vs-Grade 2
8.424000E-01
Normal-vs-Grade 3
8.676800E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
8.166900E-04
Grade 1-vs-Grade 3
1.561650E-03
Grade 1-vs-Grade 4
7.175200E-01
Grade 2-vs-Grade 3
4.738600E-01
Grade 2-vs-Grade 4
8.424000E-01
Grade 3-vs-Grade 4
8.676800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
6.964600E-01
Normal-vs-NonDiabetic
9.339600E-01
Diabetic-vs-NonDiabetic
1.341160E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
8.516000E-01
Normal-vs-NoPancreatitis
9.960600E-01
Pancreatitis-vs-NoPancreatitis
7.207600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
9.803200E-01
Normal-vs-N1
8.714600E-01
N0-vs-N1
5.184600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
3.560800E-01
Normal-vs-TP53-NonMutant
9.652800E-01
TP53-Mutant-vs-TP53-NonMutant
1.280300E-03
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
